274 related articles for article (PubMed ID: 27411805)
1. Considerations for Systemic Treatment of Psoriasis in Obese Patients.
Gisondi P; Del Giglio M; Girolomoni G
Am J Clin Dermatol; 2016 Dec; 17(6):609-615. PubMed ID: 27411805
[TBL] [Abstract][Full Text] [Related]
2. [Long-term control of psoriasis is necessary].
Sánchez Carazo JL; Martínez Casimiro L; Alegre de Miguel V
Actas Dermosifiliogr; 2008 Jan; 99 Suppl 1():29-36. PubMed ID: 18341851
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and risk profile of psoriasis patients included in the Czech national registry BIOREP and a comparison with other registries.
Kojanova M; Fialova J; Cetkovska P; Gkalpakiotis S; Jircikova J; Dolezal T; Arenberger P;
Int J Dermatol; 2017 Apr; 56(4):428-434. PubMed ID: 28181669
[TBL] [Abstract][Full Text] [Related]
4. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
Al-Mutairi N; Nour T
Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis and Obesity.
Jensen P; Skov L
Dermatology; 2016; 232(6):633-639. PubMed ID: 28226326
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic strategies against psoriasis. Skin to hide -- and how do you free your patients from it].
Stiefelhagen P
MMW Fortschr Med; 2007 Sep; 149(35-36):12-4. PubMed ID: 17944277
[No Abstract] [Full Text] [Related]
7. Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction.
Lynch M; Ahern T; Sweeney CM; Malara A; Tobin AM; O'Shea D; Kirby B
Int J Dermatol; 2017 Nov; 56(11):1103-1118. PubMed ID: 28762474
[TBL] [Abstract][Full Text] [Related]
8. Treatments for psoriasis and the risk of malignancy.
Patel RV; Clark LN; Lebwohl M; Weinberg JM
J Am Acad Dermatol; 2009 Jun; 60(6):1001-17. PubMed ID: 19344980
[TBL] [Abstract][Full Text] [Related]
9. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
10. The pharmacological management of patients with comorbid psoriasis and obesity.
Chiricozzi A; Gisondi P; Girolomoni G
Expert Opin Pharmacother; 2019 May; 20(7):863-872. PubMed ID: 30794469
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of systemic treatments for psoriasis in elderly patients.
Piaserico S; Conti A; Lo Console F; De Simone C; Prestinari F; Mazzotta A; Gualdi G; Guarneri C; Borsari S; Cassano N
Acta Derm Venereol; 2014 May; 94(3):293-7. PubMed ID: 24158307
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis is a systemic disease with multiple cardiovascular and metabolic comorbidities.
Ryan C; Kirby B
Dermatol Clin; 2015 Jan; 33(1):41-55. PubMed ID: 25412782
[TBL] [Abstract][Full Text] [Related]
13. Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry.
Carrascosa JM; Vilavella M; Garcia-Doval I; Carretero G; Vanaclocha F; Daudén E; Gómez-García FJ; Herrera-Ceballos E; De la Cueva Dobao P; Belinchón I; Sánchez-Carazo JL; Alsina M; López-Estebaranz JL; Ferrán M; Peral F; Torrado R; Rivera R; Jiménez-Puya R; Mendiola MV; Ferrándiz C;
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):907-14. PubMed ID: 23848131
[TBL] [Abstract][Full Text] [Related]
14. Psoriasis.
Burfield L; Burden AD
J R Coll Physicians Edinb; 2013; 43(4):334-8; quiz 339. PubMed ID: 24350319
[TBL] [Abstract][Full Text] [Related]
15. Compounds of psoriasis with obesity and overweight.
Owczarczyk-Saczonek A; Placek W
Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):761-772. PubMed ID: 28894050
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity.
Chiricozzi A; Raimondo A; Lembo S; Fausti F; Dini V; Costanzo A; Monfrecola G; Balato N; Ayala F; Romanelli M; Balato A
Expert Rev Clin Immunol; 2016 Dec; 12(12):1299-1308. PubMed ID: 27322922
[TBL] [Abstract][Full Text] [Related]
17. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
[TBL] [Abstract][Full Text] [Related]
18. Systemic and light therapies for the management of childhood psoriasis: part II.
Cordoro KM
Skin Therapy Lett; 2008 May; 13(4):1-3. PubMed ID: 18648714
[TBL] [Abstract][Full Text] [Related]
19. Combining traditional systemic and biologic therapies for psoriasis.
Heffernan MP
Semin Cutan Med Surg; 2010 Mar; 29(1):67-9. PubMed ID: 20430311
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis and the metabolic syndrome.
Gisondi P; Fostini AC; Fossà I; Girolomoni G; Targher G
Clin Dermatol; 2018; 36(1):21-28. PubMed ID: 29241748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
